DE69519577D1 - Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes - Google Patents

Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes

Info

Publication number
DE69519577D1
DE69519577D1 DE69519577T DE69519577T DE69519577D1 DE 69519577 D1 DE69519577 D1 DE 69519577D1 DE 69519577 T DE69519577 T DE 69519577T DE 69519577 T DE69519577 T DE 69519577T DE 69519577 D1 DE69519577 D1 DE 69519577D1
Authority
DE
Germany
Prior art keywords
prednisolonmetasulfobenzoate
colon
composition
inflammatory disease
treating inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69519577T
Other languages
English (en)
Other versions
DE69519577T2 (de
Inventor
Christopher James Speirs
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ENTEROTECH Ltd
Original Assignee
ENTEROTECH Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ENTEROTECH Ltd filed Critical ENTEROTECH Ltd
Application granted granted Critical
Publication of DE69519577D1 publication Critical patent/DE69519577D1/de
Publication of DE69519577T2 publication Critical patent/DE69519577T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69519577T 1994-08-12 1995-08-11 Prednisolonmetasulfobenzoat-zusammensetzung zur behandlung von entzündungserkrankung des darmes Expired - Lifetime DE69519577T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416310A GB2292079B (en) 1994-08-12 1994-08-12 Coated prednisolone preparation for the treatment of inflamatory bowel disease
PCT/GB1995/001900 WO1996004918A1 (en) 1994-08-12 1995-08-11 Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease

Publications (2)

Publication Number Publication Date
DE69519577D1 true DE69519577D1 (de) 2001-01-11
DE69519577T2 DE69519577T2 (de) 2001-08-09

Family

ID=10759780

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69519577T Expired - Lifetime DE69519577T2 (de) 1994-08-12 1995-08-11 Prednisolonmetasulfobenzoat-zusammensetzung zur behandlung von entzündungserkrankung des darmes

Country Status (7)

Country Link
US (1) US5834021A (de)
EP (1) EP0772443B1 (de)
CA (1) CA2229283C (de)
DE (1) DE69519577T2 (de)
DK (1) DK0772443T3 (de)
GB (1) GB2292079B (de)
WO (1) WO1996004918A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018236A1 (en) * 1995-05-08 2004-01-29 Robert Gurny Nanoparticles for oral administration of pharmaceutical agents of low solubility
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
JP2002516820A (ja) * 1997-11-13 2002-06-11 ヒスタテク・エルエルシー 低分子量ペプチド及び喘息及び炎症の治療方法
DE19855203A1 (de) * 1998-11-30 2000-05-31 Kurt Heinz Bauer Coprozessiertes Polysaccharidprodukt
US6989377B2 (en) 1999-12-21 2006-01-24 Wisconsin Alumni Research Foundation Treating vitamin D responsive diseases
US6358939B1 (en) 1999-12-21 2002-03-19 Northern Lights Pharmaceuticals, Llc Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
US20010046496A1 (en) * 2000-04-14 2001-11-29 Brettman Lee R. Method of administering an antibody
IT1318625B1 (it) 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
EP1448205B1 (de) 2001-10-05 2011-03-23 Zalicus Inc. Kombinationen für die behandlung von immun-entzündlichen erkrankungen
DK1519717T3 (da) 2002-07-05 2011-01-10 Temrel Ltd Sammensætning til kontrolleret frisætning
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
JP2007515464A (ja) * 2003-12-23 2007-06-14 テムレル・リミテッド 医薬組成物用ペレットの製造方法
GB0329851D0 (en) * 2003-12-23 2004-01-28 Temrel Inc Process for producing particles for pharmaceutical compositions
ATE437184T1 (de) 2004-01-12 2009-08-15 Applied Molecular Evolution Varianten der fc-region
AU2006316629A1 (en) * 2005-11-17 2007-05-31 Millennium Pharmaceuticals, Inc. Humanized immunoglobulin reactive with alpha 4 beta 7 integrin
US20090162434A1 (en) * 2007-12-21 2009-06-25 Disphar International Bv Mesalazine tablet
WO2010042933A2 (en) 2008-10-10 2010-04-15 Northwestern University Inhibition and treatment of prostate cancer metastasis
UA116189C2 (uk) 2011-05-02 2018-02-26 Мілленніум Фармасьютікалз, Інк. КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА
UY34054A (es) 2011-05-02 2012-11-30 Millennium Pharm Inc FORMULACIÓN PARA ANTICUERPO ANTI-a(alfa)4B(Beta)7
GB201202433D0 (en) * 2012-02-13 2012-03-28 Diurnal Ltd Controlled drug release
WO2016073897A1 (en) 2014-11-06 2016-05-12 Northwestern University Inhibition of cancer cell motility

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
FR5083M (de) * 1965-12-08 1967-05-16
FR8106M (de) * 1968-11-26 1970-07-27
US4115563A (en) * 1977-03-14 1978-09-19 Sterling Drug Inc. Pharmaceutical steroid formulation
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
KR880701098A (ko) * 1986-04-01 1988-07-25 로버어트 에이 아미테이지 메틸프레드니솔론/소디움 카르복시메틸 전분 정제 조성물
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
US5007790A (en) * 1989-04-11 1991-04-16 Depomed Systems, Inc. Sustained-release oral drug dosage form
US5178866A (en) * 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
EP0533799B1 (de) * 1990-06-20 1995-10-18 Advanced Polymer Systems, Inc. Zusammensetzungen und verfahren für die kontrollierte freisetzung von löslichen wirkstoffen
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine

Also Published As

Publication number Publication date
EP0772443B1 (de) 2000-12-06
EP0772443A1 (de) 1997-05-14
CA2229283C (en) 2005-11-08
GB2292079A (en) 1996-02-14
WO1996004918A1 (en) 1996-02-22
GB2292079B (en) 1998-07-15
DE69519577T2 (de) 2001-08-09
US5834021A (en) 1998-11-10
GB9416310D0 (en) 1994-10-05
DK0772443T3 (da) 2001-02-19
CA2229283A1 (en) 1996-02-22

Similar Documents

Publication Publication Date Title
ATE241977T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung von entzündlichen darmerkrankungen
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE69530860D1 (de) Behandlung der entzündung des sehnervs
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
ATE259812T1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69715631D1 (de) Antikonvulsive sulfamatderivate zur behandlung von fettleibigkeit
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
DE69806579T2 (de) Anlage zur behandlung von nahrungsmitteln
DE69603089D1 (de) Zusammensetzung zur behandlung von mauerwerk
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE291427T1 (de) Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms
DE69109583D1 (de) Verfahren zur Behandlung von entzündlichen Darmerkrankungen.
DE69841984D1 (de) Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ATE198751T1 (de) Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69729735D1 (de) Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
FR2758465B1 (fr) Composition pour le traitement de l'amiante
DE69518438T2 (de) Behandlung von übereregten nervenzellenfunktionen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition